The OVERCOME (Observational Survey of the Epidemiology, Treatment and Care of Migraine)
A prospective, web-based patient survey designed to follow US population samples with migraine for 2 years following their enrollment. The first population sample of 21 143 began enrollment in 2018. The study also included 10 000 people who did not have migraine, which will allow assessment of how migraine is perceived by those who do not have the disease. The second population sample of 20 782 with migraine was initiated in late 2019.